Detection of Hepatitis B Virus Genotypic Resistance Mutations by Coamplification at Lower Denaturation Temperature-PCR Coupled with Sanger Sequencing
暂无分享,去创建一个
Q. Ou | Jinpiao Lin | Huijuan Chen | Ling Jiang | Bin Yang | Can Liu | Jing Chen | Hongyan Shang | Yang Ye
[1] M. Cazzola,et al. COLD-PCR and innovative microarray substrates for detecting and genotyping MPL exon 10 W515 substitutions. , 2012, Clinical chemistry.
[2] John Quackenbush,et al. COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing. , 2012, Clinical chemistry.
[3] Jin Li,et al. Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations , 2010, Nucleic Acids Res..
[4] R. Luthra,et al. COLD-PCR finds hot application in mutation analysis. , 2009, Clinical chemistry.
[5] Cheng Li,et al. Two‐round coamplification at lower denaturation temperature–PCR (COLD‐PCR)‐based sanger sequencing identifies a novel spectrum of low‐level mutations in lung adenocarcinoma , 2009, Human mutation.
[6] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[7] M. Ghany,et al. Antiviral resistance and hepatitis B therapy , 2009, Hepatology.
[8] P. Jänne,et al. Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR. , 2009, Clinical chemistry.
[9] Vincent Leroy,et al. Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays. , 2009, Journal of virological methods.
[10] F. Monzon. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing , 2009 .
[11] Munira Hussain,et al. Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance. , 2009, Journal of hepatology.
[12] Alessandro Bruselles,et al. Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S Antigen , 2008, Journal of Virology.
[13] C. K. Chu,et al. Understanding the molecular basis of HBV drug resistance by molecular modeling. , 2008, Antiviral research.
[14] E. Schiff,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[15] H. Niesters,et al. Restriction fragment length polymorphism analysis and direct sequencing for determination of HBV genotypes in a Turkish population. , 2008, The new microbiologica.
[16] Angeline Bartholomeusz,et al. Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management , 2007, Hepatology.
[17] Y. Liaw,et al. Chronic hepatitis B: treatment alert , 2006 .
[18] S. Yu,et al. Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil , 2006, Gut.
[19] E. Schiff,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] Angeline Bartholomeusz,et al. HBV drug resistance: mechanisms, detection and interpretation. , 2006, Journal of hepatology.
[21] E. Schiff,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.